Viewing Study NCT04458259


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-03-14 @ 2:42 AM
Study NCT ID: NCT04458259
Status: TERMINATED
Last Update Posted: 2025-08-28
First Post: 2020-06-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TAMK (TAM kinase) View
None MER (mer proto-oncogene) View
None MERTK (mer proto-oncogene tyrosine kinase) View
None AXL (AXL receptor tyrosine kinase) View
None AXL/MER View
None Selective kinase inhibitor View
None PD-1 (programmed cell death protein 1) View
None PD-L1 (programmed cell death ligand 1) View
None Immune modulator View
None Advanced Cancer View
None Metastatic Cancer View
None Solid Tumor Cancer View
None Metastatic Solid Tumor View
None Cervical Cancer View
None Gastric Cancer View
None Esophageal Cancer View
None Endometrial Cancer View
None Hepatocellular carcinoma (HCC) View
None Melanoma View
None Merkel Cell Carcinoma View
None High levels of MicroSatellite Instability deficient MisMatch Repair (MSI-H-dMMR) tumor View
None Non-small cell lung cancer (NSCLC) View
None Small cell lung cancer (SCLC) View
None Renal cell carcinoma (RCC) View
None Urothelial carcinoma View
None Colorectal cancer (CRC) View